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C-Reactive Protein in Milk and Blood During Lactation
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ABSTRACT
Objective: To investigate the presence of C-reactive protein (CRP) in breast milk and any re-
lationship between changes in CRP in breast milk and blood, and the severity of systemic
and breast symptoms experienced during mastitis.
Methods: Mothers (n   26) were followed prospectively from day 5 postpartum to the end
of their lactation. Milk from each breast, blood, 24-hour urine samples and data on breast and
systemic pathologies were collected at reference intervals during the first 3 months postpar-
tum, daily during the occurrence of any breast inflammation and at 7 days after resolution of
symptoms.
Results: CRP in blood was significantly increased during mastitis (p   0.001, df:1,81; F  
31) and severity of systemic symptoms was a significant predictor for changes of CRP in blood
(p   0.01; df:3,42; F   9.6). During mastitis both the symptomatic breast (p   0.001; df:1,79; F  
19) and the contralateral asymptomatic breast (p   0.004; df:1,75; F   8.7) had a significantly
higher milk CRP when compared with women with no mastitis.
Conclusions: Although an increasing severity of breast and systemic symptoms in mastitis
was predictive of an increasing CRP in milk and blood, respectively, the presence of CRP in
similar concentrations in the mastitis and asymptomatic breast suggests it is of little use in
making a differential diagnosis between infective verses noninfective forms of mastitis.
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INTRODUCTION
E
FFECTIVE TREATMENT AND PREVENTION of mas-
titis in lactating women depends on accu-
rate identification of the underlying cause(s).
This can present dilemmas for treating clini-
cians when it is not always obvious whether
symptoms of mastitis are related to either an
infective process or an inflammatory response.
Brodribb1 has described the development of
blocked duct(s), mastitis, and breast abscess as
a continuum in which “the boundaries, espe-
cially between blocked duct(s), obstructive (in-
flammatory) mastitis and infective mastitis, are
blurred.”
Research by Osterman and Rahm2 confirms
the difficulties in establishing infective in-
volvement using clinical signs alone. Their
study found that nonpathogenic mastitis
episodes, with breast milk cultures positive for
skin flora only, can elicit equally as severe
breast and systemic symptoms as do episodes
1Attadale Private Hospital, Perth, Western Australia, Australia.
2Western Diagnostic Pathology, Myaree, Western Australia, Australia.
3School of Biomedical, Biomolecular, and Chemical Sciences, The University of Western Australia, Crawley, West-
ern Australia, Australia.with breast milk positive for potential patho-
genic bacteria. Serum C-reactive protein (CRP),
although elevated, was also not significantly
different in the two groups. Assuming that mi-
crobiologic cultivation of milk is representative
of bacterial growth at the mastitis site, their
findings indicate that neither serum CRP nor
severity of symptoms experienced are accurate
indicators as to whether an episode is either in-
fective or only inflammatory.
Although there is one report of the presence
of CRP in human colostrum,3 the response of
CRP in the breast milk of women during mas-
titis has not yet been reported. C-reactive pro-
tein in the milk of cows increased as much as
tenfold as a result of mastitis and a decrease in
the concentration of CRP in milk during anti-
biotic treatment was reflected in treatment suc-
cess.4 Another study5 measured CRP in the
milk of cows to evaluate its potential as an in-
dicator of inflammatory changes in subclinical
mastitis but found the application of CRP, as
an alternative to using cell counts was not a
useful diagnostic tool. They found, in particu-
lar, that the range detected in milk (50 to 170
 g/L) was very small, limiting its use as an in-
flammatory marker.
This study sought to investigate the presence
of CRP in breast milk during mastitis and
whether there is a relationship between
changes in CRP in breast milk and blood and
the severity of systemic and breast symptoms
suffered.
METHODS
Sample collection, recruitment, and demo-
graphics of subjects have been reported in de-
tail elsewhere;6 however, briefly in addition to
the study into CRP, the research undertaken
also sought to describe changes in milk com-
position and breast permeability during lacta-
tion mastitis.6 The study used a convenience
sample of lactating women (n   26), assessed
to be at risk for developing mastitis, who were
then followed prospectively from the fifth day
postpartum to the end of their lactation. Crite-
ria used to identify “at-risk” mothers were
based on previous research7,8 and included one
or a combination of the following: a history of
mastitis in previous lactations, nipple trauma,
attachment difficulties, and either an uncom-
fortable oversupply or engorgement at lacto-
genesis II. Reference samples of milk and 24-
hour urine were collected from women at days
5, 14, 30, 60, and 90 postpartum, and blood at
days 5 and 14, to obtain data on the normal
range of a set of potential biochemical markers
for mastitis. These included sodium (Na), chlo-
ride (Cl), lactose, glucose, serum albumin,
lactoferrin, and secretory immunoglobulin A
(sIgA) in milk and lactose in blood and urine.6
Also included in this range of markers, for the
focus of this article, were CRP in milk and
blood at days 5 and 14 postpartum.
Eighty-eight percent (88%, n   23) of the
sample were exclusively breastfeeding during
reference sampling, three mothers were offer-
ing one to three complementary feeds/24
hours at day 90; and one mother who initially
experienced low supply was offering supple-
mentary feeds from day 5 to 21, but was there-
after exclusively breastfeeding. Women were
interviewed at collection times to establish any
coexisting breast (e.g., nipple trauma, low sup-
ply) or systemic pathologies. If women suffered
with mastitis at any time during their lactation,
further samples were collected daily during the
course of their mastitis and at follow-up 7 days
after resolution of symptoms. If the mother had
not already commenced antibiotic treatment at
the time of the researcher’s first visit (day 1 of
the episode), milk also was collected for culture
and sensitivity of aerobic bacteria. Women with
mastitis completed a symptom log to provide
descriptive data on the characteristics and
management surrounding the onset and dura-
tion of their mastitis.
The study was approved by The University
of Western Australia, Human Research Ethics
Committee.
Operational definitions
Breast inflammation. Breast inflammation was
defined as a warm to hot, red, and tender or
painful area of the breast. It was further cate-
gorized as localized, segmental, or total breast
inflammation according to the area of inflam-
mation present.
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defined as mild (feels unwell, tires easily,
afebrile [body temperature (T°)  37.5°C]);
acute (unwell, T°  37.4°C and  38.5°C, myal-
gia, needs to go to bed); and hyperacute (T°
 38.4°C, myalgia, headache or vomiting, rig-
ors).
If overlap of symptoms between categories
occurred, T° would be the primary defining
factor. Any inflammation of the breast present
for more than 24 hours and accompanied by
any degree of systemic illness was categorized
as mastitis.
Measurement of C-reactive protein in milk 
and serum
C-reactive protein in milk and serum was
quantified at a commercial laboratory by Rate
Nephelometer (Beckman-Immage®, Gladesville,
New South Wales, Australia) using CRP reagent
kits supplied by Beckman Instruments, Inc. The
recovery of a known amount of serum CRP
added to defatted milk samples was 90.5   5.6%
(n   10). Interassay CV was determined using
Dade Behring Immuno 1 (10 mg/L) and 3 (38
mg/L) and was 4.4% (n   41) and 6.3% (n   41),
respectively. Sensitivity for serum and milk CRP
determination was 1 mg/L.
Bacteriologic analysis of milk
The nipple and areola areas of each breast
were cleaned with sterile water and allowed
to dry. Using gloves, the first 5 mL (approxi-
mate) were expressed into a clean sample
tube for biochemical analyses and a further
midstream sample was then expressed into a
sterile 5-mL polypropylene tube. The mid-
stream sample was transported on ice and
stored at 4°C for no longer than 6 hours, when
100  L was then cultured on horse blood and
chocolate agar, both formulations using oxoid
agar bases. Each plate was air dried in 35°C
for 45 minutes and dried before inoculating
each agar plate with sample. Both plates were
incubated at 35°C in an 8% CO2 atmosphere
for a total of 48 hours. Colony counts were
performed at 24 hours incubation and again
at 48 hours. The identification of the different
species and their antibiotic sensitivity was
carried out by a range of classical characteri-
zation tests.9
Statistical analysis
Descriptive statistics used means and stan-
dard deviations or medians and interquartile
ranges, as appropriate, depending on nor-
mality. Hypothesis testing of all outcome
measures was based on analysis of variance
with repeated measures within a mixed
model10 (MIXED procedure). Models were
used in which individual women were
treated as random effects and comparison
groups (e.g., mastitis/no mastitis) as fixed ef-
fects.
In the analysis of outcomes that occurred at
various stages of lactation appropriate adjust-
ment, using stage of lactation (day postpartum)
as one of the covariates in analysis of variance
models, were made. Estimate effects were pre-
sented as means and 95% confidence intervals
(95% CI). Any p-values   0.05 were considered
significant. All data was analyzed using the
mixed model module (MIXED) in SPSS 11.0 for
Mac OSX (2002).
RESULTS
Mastitis incidence
The sample of 26 women yielded 14 women
suffering a total of 22 episodes of mastitis. Two
women experienced one episode each of bilat-
eral mastitis. Range of occurrence was from
day 5 to day 400 postpartum. Fifty-four percent
(54%, n   12) of episodes were experienced in
the first 30 days.
C-reactive protein response in blood 
and milk postparturition
The concentration of CRP in the blood of
women with asymptomatic breasts ranged
from 9 to 45.5 mg/L on day 5 (n   12) and 1 to
102 mg/L on day 14 (n   10) postpartum. The
concentration of CRP in milk from asympto-
matic breasts ranged from below the level of
detection to 1.91 mg/L in samples on day 5
(n   25 breasts) and below the level of detec-
tion to 3.0 mg/L on day 14 (n   26).
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ing to type of birth in women without mastitis.
Results for days 5 and 14, respectively, are
shown in Table 1.
Breast milk bacteriology during mastitis
Breast milk was collected for culture, sensi-
tivity, and leucocyte and bacterial counts from
both breasts of nine women experiencing 13
mastitis episodes (two bilateral episodes, n  
15 mastitis breasts). In the remaining episodes,
samples for culture were not collected because
women had already commenced antibiotics be-
fore the visit from the researcher. Only samples
from two of the 13 episodes cultured positive
for pathogens. Staphylococcal aureus was cul-
tured in one single breast episode and peni-
cillin-resistant S. aureusin one bilateral episode.
Milk from the other bilateral episode contained
scant to moderate leucocytes and  103 cfu/mL
of Streptococci (Strep) viridans and coagulase-
negative staphylococci (CNS). Milk from seven
of the remaining nine single breast nonpatho-
genic episodes showed higher counts ( 103) of
CNS and/or Streptococci viridans in the affected
breast than in the unaffected breast
C-reactive protein response during mastitis
C-reactive protein (CRP) was measured daily
in both the milk and blood of women who con-
sented to sampling during mastitis episodes
and at follow-up (7 days after resolution of
mastitis symptoms). The concentration of CRP
in blood for mastitis samples (n   36) ranged
from 7 to 316 mg/L (mean   65.5   62.9).
Mean serum CRP was highest (77   58 mg/L)
on day 2 of mastitis episodes. The concentra-
tion of CRP in blood, on the second mastitis
day, for the infective episodes of mastitis (S. au-
reus, n   2) was variable (55 and 145 mg/L)
when compared with the mean serum CRP for
the noninfective mastitis episodes (68   51
mg/L). When adjusted for stage of lactation,
the concentration of CRP in blood was signifi-
cantly increased during mastitis (p   0.001;
df:1,81; F   31); however, mixed model analy-
sis did not find any particular day of the mas-
titis episodes (first, second third, fourth, or fifth
day) to be a significant predictor for CRP con-
centration in blood (p   0.75; df:3,28; F   0.4;
Fig. 1). When adjusting for coexisting patholo-
gies and stage of lactation, the concentration of
CRP in blood at follow-up was not significantly
different from women without mastitis with
asymptomatic breasts (p   0.55; df:1,44; F  
0.4).
The mixed model analyses showed the con-
centration of CRP in blood increased according
to both the severity of breast and systemic
symptoms (Fig. 2). The model for severity of
systemic symptoms was a significant predictor
for change in the concentration of CRP in blood
(p   0.01; df:3,42; F   9.6), whereas the sever-
ity of breast symptoms did not predict changes
in blood CRP (p   0.37; df:2,31; F   1.0). The
estimated means (95% CI) and significance val-
ues for type of symptoms from the mixed ef-
fects models are shown in Figure 2.
During mastitis, the concentration of CRP in
milk from the mastitis breast ranged from be-
low the level of detection to 5.2 mg/L and sim-
ilarly the concentration in the contralateral
asymptomatic breast ranged from below the
level of detection to 4.8 mg/L. Both the symp-
tomatic mastitis breast (p   0.001; df:1,79; F  
19) and contralateral asymptomatic breast (p  
0.004; df:1,75; F   8.7) had a significantly
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TABLE 1. MEDIAN (25, 75 QUARTILE) C-REACTIVE PROTEIN (MG/L) IN BLOOD AND MILK OF WOMEN
WITHOUT MASTITIS ACCORDING TO TYPE OF BIRTH AT DAY 5 AND DAY 14 POSTPARTUM
CRP Spontaneous Nonelective Elective
(mg/L) vaginal birth Vacuum birth Cesarean birth Cesarean birth
Day 5 18.9 (6.7, 25.9) 14.9 (11.5, 18.3) 30.3 (16.8, 67.5) 48 (12.4, 58.2)
(blood) n   7 women n   3 n   5 n   9
Day 14 (blood) 2.2 (1.0, 38.5) 3.7 (2.0, 5.4) 6.8 (4.5, 57) 3.5 (1.7, 10.6)
Day 5 (milk) 0 (0, 1) 1.5 (0, 2.1) 1.0 (0, 1.6) 0 (0, 0)
n   14 breasts n   6 n   10 n   18
Day 14 (milk) 0 (0, 1.2) 1.1 (0, 1.6) 0 (0, 0.3) 0 (0, 0)higher milk CRP when compared with women
who did not have mastitis. The estimated mean
(95% CI) for concentration of CRP in milk from
the mixed model was 2.0 mg/L (1.4, 2.6) in
mastitis breasts (n   58) and 1.76 mg/L (1.1,
2.4) in contralateral asymptomatic breasts (n  
41). This was not significantly different (p  
0.221; df:1,87; F   1.5). The concentration of
CRP in milk increased over the period of the
mastitis episode to reach a peak on day 4 of the
episode (2.3 mg/L); however, the statistical
model was not significant (p   0.31; df:4,41;
F   1.2) (Fig. 3). The mean for the two infective
(S. aureus) episodes (2.9 mg/L) was higher than
the mean milk CRP of noninfective mastitis
breasts (2.0 mg/L). When adjusted for coexist-
ing pathologies and stage of lactation the con-
centration of CRP in milk from mastitis breasts
(n   12) at follow-up (7 days after resolution of
symptoms) was not significantly different (p  
0.21; df:1,57; F   1.6) from the concentration of
CRP in milk from women without mastitis with
asymptomatic breasts (n   49 breasts).
C-reactive protein response in breast milk
during mastitis was observed to increase
with severity of breast symptoms (Fig. 4). The
concentration of CRP in milk was within a
very narrow range compared with the con-
centration of CRP in blood, and the predic-
tive model for severity of breast symptoms
was not significant (p   0.82; df:2,47; F  
0.2). Severity of systemic symptoms also was
not a significant predictor for change in the
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FIG. 1. Descriptive data (median, interquartile range)
for C-reactive protein (CRP) (mg/L) in blood for each day
of mastitis episodes (day 1 to day 4). Concentrations of
CRP in blood for women with asymptomatic breasts (no
mastitis) and at follow-up 7 days after resolution of mas-
titis are included for comparison. The no mastitis cases
include reference measurements at day 5 and day 14 post-
partum when CRP may have been elevated after trauma
from birth. Outliers ( 2 box lengths) are shown as 0 and
extremes ( 3 box lengths) as *.
FIG. 2. Estimated means (95% CI) from the mixed model analysis for C-reactive protein (CRP) in blood according
to the severity of systemic symptoms (A) and breast symptoms (B) experienced during mastitis. Follow-up data are
included in (B). The midpoint represents the estimated mean with upper and lower points, the 95% CI.
A
Bconcentration of CRP in milk (p   0.59;
df:3,45; F   0.63). The estimated means 
(95% CI) from the mixed models are shown
in Figure 4.
DISCUSSION
The concentration of CRP in breast milk at
days 5 and 14 postpartum was generally below
the level of detection in women without mas-
titis ( 1 mg/L), despite significantly increased
concentrations of CRP in blood. Previously re-
ported concentrations of 8 to 12 mg/L in
colostrum at 36 to 48 hours postpartum3 were
not accompanied by results of recoveries or co-
efficients of variance. However, assuming the
validity of this report, these comparatively high
concentrations may be explained by the in-
creased paracellular pathway permeability
present at this time. The dramatic drop to neg-
ligible concentrations at day 5 in this study is
commensurate with closure of the tight junc-
tions, which is largely complete by 72 hours.11
The increased CRP in blood in the postpar-
tum period is likely to have resulted from tis-
sue trauma associated with birth and birth 
interventions. Whereas previous studies12,13 re-
ported peak CRP concentrations in blood
rapidly decreasing to baseline after the second
or third day postpartum, the present study
CRP concentrations remained increased at day
5 postpartum and a high variation above the
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FIG. 3. Descriptive data for C-reactive protein (CRP)
(mg/L) in milk on each day of mastitis episodes (day 1
to day 5). Concentrations of CRP in milk for women with
asymptomatic breasts (no mastitis) and at follow-up after
mastitis are included for comparison. The no mastitis
cases include reference measurements at day 5 and day
14 postpartum when the mean CRP was below the level
of detection.
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FIG. 4. Estimated means (95% CI) from the mixed model analysis for C-reactive protein (CRP) (mg/L) in milk ac-
cording to the severity of breast symptoms (A) and systemic symptoms (B) experienced during mastitis. Data from
women with asymptomatic breasts (no mastitis), the contralateral asymptomatic breast and the mastitis breast at fol-
low-up is included in (A).
B Amean was observed, particularly for sponta-
neous vaginal and nonelective Cesarean sec-
tions at day 14 postpartum.
Recruiting breastfeeding women with
known risk factors for mastitis, in particular, a
past history of mastitis and/or nipple trauma,
and attachment difficulties, provided an effi-
cient means of obtaining a high incidence of
mastitis with a wide range of severity of symp-
toms appropriate for the observation of
changes in CRP and other components in breast
milk. However, because of the specific nature
of the sample, these results should not be gen-
eralized to a normal population.
The concentrations of CRP in blood observed
during mastitis were similar to those reported
by Osterman and Rahm2who reported the high-
est observed CRP at 280 mg/L with a mean of
61.5 mg/L in 40 women presenting with masti-
tis. The slightly lower results obtained, com-
pared with the authors’ study (mean 77 mg/L,
highest 316 mg/L), may result from the time of
sampling. Although not stated, it is assumed
samples were taken on the first day of mastitis
presentation, whereas the peak mean CRP ob-
served in the authors’ study occurred on the sec-
ond day of mastitis episodes. As the most acute
symptoms were experienced during the first day
of mastitis, the delay in peak observed CRP was
expected, because the plasma level can double
every 8 hours in the presence of continuing in-
flammatory stimulus.14
An increasing severity of systemic symptoms
in mastitis was predictive of an increasing con-
centration of CRP in blood. Blood CRP also in-
creased with escalating severity of breast
symptoms; however, the differences among lo-
calized, segmental, and inflammation of the
whole breast were not significantly predictive.
Women who had recovered from systemic
symptoms but breast symptoms had not yet re-
solved had a mean concentration of CRP in
blood   10 mg/L, which is considered nor-
mal.14 This rapid fall occurs because of the
short half-life of CRP of 5 to 7 hours. This in-
dicates that the presence of systemic symptoms
in mastitis is a stronger predictor than breast
inflammation for a raised concentration of CRP
in blood.
The increase in the concentration of CRP in
milk during mastitis did not reach the levels re-
ported by Abdulla et al. in colostrum3 despite
elevated concentrations in blood. This may
suggest the increase in paracellular pathway
permeability in response to mastitis may be
only localized resulting in less movement of
CRP into the milk space compared with that
occurring during the first 48 hours postpartum
when there is believed to be uniform pathway
permeability present. Although the source of
CRP in milk cannot be positively determined,
the association between breast symptoms and
the concentration of CRP in milk indicates there
is either some local production or transfer of
CRP to the site in a dose-related response to the
severity of local inflammation. The presence of
an increased CRP in milk from the asympto-
matic breast suggests an additional systemic
source; however, there was no relationship ob-
served between CRP in milk and the CRP in
blood at day 5 or 14 that supports the latter pro-
posal. An explanation for the observed rise in
milk CRP in the contralateral asymptomatic
breast is illusive, particularly because the other
milk components measured in this breast were
within normal range.6
Bacteriology
Only two (one bilateral) of the 13 tested
episodes of mastitis had breast milk cultures
from the mastitis breast(s) that were positive
for the growth of pathogenic bacteria. Previ-
ously, when breast milk culture has been neg-
ative during mastitis, there has been some
doubt as to whether milk obtained for culture
was representative of the affected area. How-
ever, the changes observed in milk composition
combined with the increased excretion of lac-
tose in the urine6 indicate that the milk ex-
pressed was representative of milk from the in-
flamed or infected area of the breast.
There was a high count (103 to 105 cfu) of
Strep. viridans and/or CNS present in the milk
from affected breasts (both pathogenic and
nonpathogenic) compared with asymptomatic
breasts. It cannot be discounted that the pres-
ence of either CNS or Strep. viridans within the
breast, especially when present in high num-
bers, may be the causative mechanism for what
is normally considered “noninfective” episodes
of mastitis experienced by the women in this
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a normal commensal, most abundant in the hu-
man mouth and pharynx. Some of these or-
ganisms can cause brief low-grade bacteremias
when they pass into the circulation, via injury
to the gums. However, generally they are
cleared rapidly from the circulation as they do
not possess protective devices against host de-
fenses.15 The source of Strep. viridans in the
breast milk of these women could have been
through hematogenous spread, but it is most
likely to have been through the nipple from the
infant’s mouth. Matheson et al.16 found Strep.
viridans present in only 8% of milk samples
from healthy women; a relatively low percent-
age compared with its presence in 7 of the 13
nonpathogenic mastitis breasts cultured from
women with mastitis in this study.
Coagulase-negative staphylococci were iso-
lated in all mastitis samples cultured in the
present study in numbers ranging from 103 and
105 cfu/mL. The presence of CNS is generally
disregarded as being either a contaminant from
the skin or at least a normal occurrence in
breast milk, with 86% of milk samples from
healthy donors containing CNS.17 However,
these isolates were present in counts greater
than 102 cfu/mL, despite being midstream
samples. Abakada et al.17 found that CNS ap-
peared to have some pathogenicity in the
breasts of women with mastitis, with S. epider-
midis appearing to be the most virulent. Path-
ogenic strains of CNS have been described 
previously18 and also considered as possible
causative factors in the occurrence of mastitis.19
CONCLUSION
The concentration of CRP found in the milk
from breasts of women with mastitis was
much lower (1/60) than that observed in
blood; however, it was still considerably
higher than that detected in cows milk (1 to
5 mg/L compared with 50 to 170  g/L, re-
spectively). Because of the low concentrations
of CRP observed in milk, an alternate assay
method with a lower sensitivity level com-
pared with the commercial rate nephelome-
try used in this study may be more discern-
ing of the changes in CRP. As paracellular
pathway permeability was found to be nor-
mal in the unaffected breast during mastitis,6
the presence of CRP in the milk from both the
mastitis and contralateral asymptomatic
breast appear to indicate some active trans-
port of CRP into the milk compartment, or de
novo synthesis. There was no observed rela-
tionship between the concentrations of CRP
in milk and blood either during mastitis or
the immediate postpartum period, although
increasing severity of breast symptoms did
result in an increasing concentration of CRP
in milk. However, the increase was not sta-
tistically predictive because the range in con-
centration of CRP observed in milk was very
narrow. This, and its presence in the asymp-
tomatic breast in similar concentrations to the
mastitis breast, suggest it is of little use in
making a differential diagnosis between in-
fective and noninfective forms of mastitis.
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